Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Ashok Gowda
AddedMar 31, 2024
UpdatedJun 28, 2026
Ashok Gowda

Ashok Gowda

Board Member, Base Pair Biotechnologies

LinkedIn

Ashok Gowda's Career

Base Pair Biotechnologies
Base Pair Biotechnologies

Pearland, TX, US

Board Member· Board
Ictero Medical
Ictero Medical

Houston, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Ashok Gowda's Career

Base Pair Biotechnologies
Base Pair Biotechnologies
Seed$3.2M82011Pearland, TX, US
Board Member· Board

Leadership at Base Pair Biotechnologies

Bill JacksonBill JacksonFounder
Ictero Medical
Ictero Medical
Series A$14.8M62018Houston, TX, US
Board Member· Board

Leadership at Ictero Medical

Matthew NojoomiMatthew NojoomiCo-Founder
Kovi BessoffKovi BessoffCo-Founder

Similar to Ictero Medical

Ionix MedicalIonix MedicalMaple Grove, MN, USMedical Devicesest. 2001Ionix MedicalMaple Grove, MN, US · est. 2001

Ionix Medical: Innovating minimally-invasive prostate treatments with proprietary ablation technology.

Series B · $18.3M6
CryoMedixCryoMedixSan Diego, CA, USMedical Devicesest. 2007CryoMedixSan Diego, CA, US · est. 2007

CryoMedix pioneers in next-gen cryoablation technology with four pending patents.

Pre-Seed · $500k6
Intact MedicalIntact MedicalFramingham, MA, USMedical Devicesest. 2002Intact MedicalFramingham, MA, US · est. 2002

US-based Intact Medical Corp. develops minimally invasive systems.

Pre-Seed · $25.7M7
Micro Medical SolutionsMicro Medical SolutionsWilmington, MA, USMedical Devicesest. 2013Micro Medical SolutionsWilmington, MA, US · est. 2013

Micro Medical Solutions develops microvascular intervention therapies for peripheral artery disease.

Series B · $27.2M11

Ashok Gowda's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Ashok Gowda

Ashok KrishnamurthiAshok KrishnamurthiBoard Member · Linus BiotechnologyChris SmithChris SmithBoard Member · NeoGenomics LaboratoriesMatthew WolfsonMatthew WolfsonBoard Member · Electromedical TechnologiesDhanushka P ArachchigeDhanushka P ArachchigeBoard Member · Olenox IndustriesShaun AndrikopoulosShaun AndrikopoulosFounder · Teton Sports & Spine ImagingKen MayerKen MayerFounder · GTV